Recent News

• 10.16.2025 - Q/C Technologies Appoints Technion Professor Dr. Steven Frankel as Senior Quantum Advisor to Advance Photonic and Quantum-Class Computing Initiatives
• 09.25.2025 - Q/C Technologies (Formerly TNF Pharmaceuticals) Commences Trading on Nasdaq Under New Ticker Symbol “QCLS”
• 09.24.2025 - TNF Pharmaceuticals Announces Name Change to Q/C Technologies and New Ticker Symbol “QCLS” to Reflect Strategic Focus on Quantum Class Photonic Computing
• 09.17.2025 - TNF Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement
• 09.08.2025 - TNF Pharmaceuticals to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Recent Filings

• 10.10.2025 - PRE 14A Other preliminary proxy statements
• 10.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.06.2025 - 3 Initial statement of beneficial ownership of securities
• 10.06.2025 - 8-K/A Current report
• 10.06.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.03.2025 - S-3 Registration statement under Securities Act of 1933
• 10.03.2025 - 8-K Current report